Quantifying the cost burden of hepatitis C

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      2019 US dollars

    Reference

    1. Mattingly TJ 2nd, et al. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. PharmacoEconomics : 12 Jun 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00933-3

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Quantifying the cost burden of hepatitis C. PharmacoEcon Outcomes News 856, 28 (2020). https://doi.org/10.1007/s40274-020-6928-9

    Download citation